drugset / Trial / NCT03540368

Tranexamic Acid for The Treatment of Gastrointestinal Bleeding

NCT03540368 ↗

Completed 48 enrolled Indonesia University
RandomizedParallel-groupSingle-blindTreatment

Summary

Studies showed that in cases of gastrointestinal bleeding, injection tranexamic acid decreasing the risk of death and the need of surgical intervention. However, the quality of most clinical trials were not good and the results were not significant. Injection tranexamic acid does not become one of the treatment option in the international guidelines nor in national consensus, so the effectiveness and the safety of its use in the treatment of gastrointestinal bleeding remains unclear and not routinely used. In Indonesia, injection tranexamic acid in gastrointestinal bleeding is limitedly used and recorded. Therefore, a clinical trial study of injection tranexamic acid is required to assess the effectiveness and the safety in the treatment of gastrointestinal bleeding.

Timeline

Start
2018-07-01
Primary completion
2019-03-01
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 3 g Intravenous

Indications

No indication recorded.